Page 2 - வேரா சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வேரா சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வேரா சிகிச்சை இன்க் Today - Breaking & Trending Today

Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease


Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease
Potential first-in-class disease-modifying biologic in late-stage clinical studies
Experienced executive development team from Gilead Sciences
News provided by
Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 /PRNewswire/  Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases, today announced its launch backed by $80 million Series C financing led by Abingworth LLP. Other investors included Sofinnova Investments, Longitude Capital, Fidelity Management & Research Company LLC, Surveyor Capital (a Citadel company), Octagon Capital, Kleiner Perkins, GV (formerly Google Ventures), and Alexandria Venture Investments. ....

United States , Menlo Park , Al Iskandariyah , City Of , United Kingdom , Andrew Cheng , Kleiner Perkins , Tom Doan , Scott Morrison , Marshall Fordyce , Joanne Curley , Maha Katabi , Beth Seidenberg , Lauren Frenz , Gilead Sciences , Company Board Of Directors , Us Life Sciences Leader , Vera Therapeutics Inc , Fidelity Management Research Company , Merck Kga , Ernst Young , Merck Kgaa , Vera Therapeutics , Sofinnova Investments , Longitude Capital , Fidelity Management ,